Strides Pharma Science has enclosed Press Release (along with Earnings presentation) issued by the Company titled: ‘Strides Delivers a Robust Q2FY26 with Highest Ever Quarterly EPS Q2FY26 Operational PAT at ?1,403m and EPS at ?15.2, Grew 84% YoY’. The meeting commenced at 11:30 hrs IST and concluded at 12:50 hrs IST. The above information will also be available on website of the Company at www.strides.com
The above information is a part of company’s filings submitted to BSE.